Korean Drug Co Ltd
KOSDAQ:014570
Korean Drug Co Ltd
Inventory
Korean Drug Co Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
Korean Drug Co Ltd
KOSDAQ:014570
|
Inventory
₩19.6B
|
CAGR 3-Years
14%
|
CAGR 5-Years
10%
|
CAGR 10-Years
11%
|
|
|
Yuhan Corp
KRX:000100
|
Inventory
₩337.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
5%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Inventory
₩104B
|
CAGR 3-Years
14%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Inventory
₩319.1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
8%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Inventory
₩47.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
10%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Inventory
₩22.7B
|
CAGR 3-Years
41%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Korean Drug Co Ltd
Glance View
KOREAN DRUG Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. The company is headquartered in Icheon, Gyeonggi-Do and currently employs 256 full-time employees. The company went IPO on 2000-12-07. The Company’s products portfolio consists of over-the-counter (OTC) medicines, ethical (ETC) medicines and health food, including multi-symptom cold medicines, blood-forming nutrients, treatments for central nervous system, remedies for respiratory diseases, dermatological agents, vitamins, antifungal agents, antipyretics, analgesics, anti-inflammatory drugs, antibiotics, allergic treatments, calcium and vitamin D tablets and home pregnancy test kits, among others.
See Also
What is Korean Drug Co Ltd's Inventory?
Inventory
19.6B
KRW
Based on the financial report for Sep 30, 2025, Korean Drug Co Ltd's Inventory amounts to 19.6B KRW.
What is Korean Drug Co Ltd's Inventory growth rate?
Inventory CAGR 10Y
11%
Over the last year, the Inventory growth was -12%. The average annual Inventory growth rates for Korean Drug Co Ltd have been 14% over the past three years , 10% over the past five years , and 11% over the past ten years .
